Safety of capecitabine plus bevacizumab in heavily treated patients with metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Adamo, Vincenzo [1 ]
Festa, Vincenzo [1 ]
Restuccia, Eleonora [1 ]
Chiofalo, Giuseppe [1 ]
Maisano, Carmelo [1 ]
Picciotto, Maria [1 ]
Alafaci, Elisabetta [1 ]
Tortora, Giampaolo [2 ]
机构：
[1] AO Univ Polyclin G Martino, Dept Human Pathol, Med Oncol & Integrated Therapies Unit, Messina, Italy
[2] Univ Naples Federico 2, Dept Mol & Clin Endocrinol & Oncol, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [1] Safety of the combination capecitabine plus bevacizumab in the treatment of heavily treated advanced colorectal cancer patients: Our experience
    Adamo, V
    Festa, V
    Adamo, B.
    Franchina, T.
    Iorfida, M.
    Maugeri, Sacca M.
    Montalto, E.
    Rossello, R.
    Tortara, G.
    ANNALS OF ONCOLOGY, 2007, 18 : VII68 - VII69
  • [2] Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC)
    Solis Hernandez, Maria Del Pilar
    Jimenez, Paula
    Faez Garcia, Laura
    Alvarez Fernandez, Carlos
    Perez Arnillas, Quionia
    Rodriguez Rubi, David Jose
    Lucrecia Ruiz, Ana
    Sanchez Lorenzo, Luisa
    Li Torres, Walter Antonio
    Uriol, Esther
    Dolores, Maria
    Prieto, Menendez
    Maria Vieitez de Prado, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer
    M. Degirmenci
    B. Karaca
    G. Gorumlu
    R. Durusoy
    G. Demir Piskin
    M. T. Bozkurt
    Y. Cirak
    D. Tunali
    B. Karabulut
    U. A. Sanli
    R. Uslu
    Medical Oncology, 2010, 27 : 585 - 591
  • [4] Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in patients with metastatic colorectal cancer (mCRC)
    Garcia Alfonso, P.
    Chaves, M.
    Munoz Martin, A.
    Salud Salvia, A.
    Vilchez, R.
    Yuste, A.
    Gravalos Castro, C.
    Queralt Merino, B.
    Gonzalez Flores, E.
    Lopez Ladron, A.
    Losa, F.
    Oltra Ferrando, A.
    Gomez Reina, M. J.
    Campos, J. M.
    Aranda, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer
    Degirmenci, M.
    Karaca, B.
    Gorumlu, G.
    Durusoy, R.
    Piskin, G. Demir
    Bozkurt, M. T.
    Cirak, Y.
    Tunali, D.
    Karabulut, B.
    Sanli, U. A.
    Uslu, R.
    MEDICAL ONCOLOGY, 2010, 27 (03) : 585 - 591
  • [6] PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF IRINOTECAN, CAPECITABINE AND BEVACIZUMAB IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS
    Garcia Alfonso, Pilar
    Chaves, Manuel
    Munoz, Andres
    Salud, Antonieta
    Garcia-Giron, Carlos
    Gravalos, Cristina
    Massuti, Bartomeu
    Gonzalez-Flores, Encarnacion
    Queralt, Bernardo
    Lopez-Ladron, Amelia
    Losa, Ferran
    Oltra, Amparo
    Jose Gomez, Ma
    Manuel Campos, J.
    Aranda, Enrique
    ANNALS OF ONCOLOGY, 2012, 23 : 103 - 104
  • [7] Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in metastatic colorectal cancer (mCRC) patients
    Garcia Alfonso, Pilar
    Chaves-Conde, Manuel
    Munoz, Andres
    Salud, Antonia
    Garcia-Giron, Carlos
    Gravalos Castro, Cristina
    Massuti, Bartomeu
    Gonzalez Flores, Encarnacion
    Queralt, Bernardo
    Lopez Ladron, Amelia
    Losa, Ferran
    Oltra Ferrando, Amparo
    Gomez Reina, Maria Jose
    Garcia-Carbonero, Rocio
    Garcia-Escobar, Ignacio
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [8] Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer
    Larsen, Finn Ole
    Boisen, Mogens Karsbol
    Fromm, Annelene L.
    Jensen, Benny Vittrup
    ACTA ONCOLOGICA, 2012, 51 (02) : 231 - 233
  • [9] EFFECTIVENESS AND SAFETY OF FIRST-LINE BEVACIZUMAB PLUS FOLFIRI IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Pinto, Ana Catarina
    Teixeira, Margarida
    Bonito, Nuno
    Jacinto, Paula
    Ribeiro, Joao
    Gervasio, Helena
    ANNALS OF ONCOLOGY, 2011, 22 : v98 - v98
  • [10] Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
    Bocobo, Andrea Grace
    Wang, Renee
    Behr, Spencer
    Carnevale, Julia C.
    Cinar, Pelin
    Collisson, Eric Andrew
    Fong, Lawrence
    Keenan, Bridget P.
    Kidder, Wesley Allen
    Ko, Andrew H.
    Kolli, Kanti Pallav
    Kennedy, Megan
    Laffan, Angela
    Piawah, Sorbarikor
    Pollak, Marin
    Schwartz, Gabriel
    Whitman, Julia
    Zhang, Li
    Van Loon, Katherine
    Atreya, Chloe Evelyn
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345